Skip to main content
. 2022 Nov 22;9:1024193. doi: 10.3389/fmolb.2022.1024193

FIGURE 3.

FIGURE 3

The cfDII-fragmentation following normalization with cellular genomic DNA for comparison among healthy, CLD and HCC patients. The ALU gene cfDII-fragmentation among healthy, CLD and HCC patients following normalization with cellular genomic DNA (A). The ROC plot of ALU gene cfDII-fragmentation differentiating HCC from healthy subjects (B), HCC from CLD patients (C). The GAPDH gene cfDII-fragmentation among healthy, CLD and HCC patients following normalization with cellular genomic DNA (D). The ROC plot of ALU gene cfDII-fragmentation differentiating HCC from healthy subjects (E), HCC from CLD patients (F). ns- Non significant, *- p value = 0.01, **- p value = 0.005, ****- p value < 0.0001.